TYRA stock news

TYRA stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

16 wire items

2026-10-28 06:04:39 UTC#526229updateconfirmednews

BlueNord Q3 net loss $19.7M on derivative hits despite Tyra-led production gains; Vår Energi merger on track

quartrimportance 0.40trust 0.70BlueNord ASA +0.20Vår Energi ASA +0.20Tyra +0.60

2026-10-28 06:04:28 UTC#526232duplicateconfirmednews

BlueNord Q3 revenue $346M, EBITDA $221M, production 43.6 mboe/d; Vår Energi merger on track for year-end

quartrimportance 0.40trust 0.70BlueNord ASA +0.40Tyra +0.60Vår Energi ASA +0.30

2026-09-22 17:21:00 UTC#350725updateconfirmednews

Oppenheimer cuts Tyra Biosciences price target to $40 from $50

dow_jonesimportance 0.30trust 0.70Tyra Biosciences, Inc. -0.30Oppenheimer & Co. Inc. -0.30

2026-09-22 17:10:40 UTC#350683newconfirmedanalysis

Oppenheimer reiterates Outperform rating on Tyra Biosciences, sets $40 price target

tradingviewimportance 0.40trust 0.70Oppenheimer Holdings Inc. +0.20Tyra Biosciences, Inc. +0.40

2026-09-22 10:19:54 UTC#347786newconfirmednews

H.C. Wainwright maintains Buy rating on Tyra Biosciences, sets $29 price target

tradingviewimportance 0.30trust 0.60H.C. Wainwright & Co. +0.20Tyra Biosciences, Inc. +0.30

2026-09-14 14:30:00 UTC#308077duplicateconfirmednews

Tyra Biosciences shares trade higher following $400 million equity offering pricing

dow_jonesimportance 0.30trust 0.80Tyra Biosciences, Inc. -0.30dabogratinib +0.20

2026-09-14 10:54:12 UTC#306604duplicateconfirmednews

Tyra Biosciences prices $400 million equity offering to fund dabogratinib development

seeking alphaimportance 0.30trust 0.80Tyra Biosciences, Inc. -0.30dabogratinib +0.20

2026-09-14 10:45:00 UTC#306538duplicateconfirmedpress release

Tyra Biosciences Announces Pricing of $400 Million Common Stock and Pre-Funded Warrants Offering

pr newswireimportance 0.30trust 1.00Tyra Biosciences, Inc. -0.30

2026-09-14 10:45:00 UTC#306512newconfirmedpress release

Tyra Biosciences prices $400 million offering of common stock and pre-funded warrants at $22.03 per share

pr_newswireimportance 0.50trust 1.00Tyra Biosciences, Inc. -0.30

2026-09-10 13:10:00 UTC#292355newconfirmednews

Wedbush maintains $53.00 price target on Tyra Biosciences (TYRA)

dow_jonesimportance 0.30trust 0.70Tyra Biosciences, Inc. 0Wedbush Securities Inc. 0

2026-09-09 11:51:55 UTC#286062newconfirmednews

Tyra Biosciences shares fall following mid-stage bladder cancer trial data

seeking alphaimportance 0.60trust 0.70Tyra Biosciences, Inc. -0.70

2026-09-04 16:16:00 UTC#269408newconfirmednews

H.C. Wainwright & Co. maintains $45.00 price target on Tyra Biosciences (TYRA)

dow_jonesimportance 0.30trust 0.60Tyra Biosciences, Inc. 0H.C. Wainwright & Co., LLC 0

2026-09-04 15:47:58 UTC#269279updateconfirmednews

Tyra Biosciences shares rise ahead of Sept 9 Phase 2 SURF302 study results for dabogratinib

seeking alphaimportance 0.40trust 0.60Tyra Biosciences, Inc. +0.40

2026-09-04 12:00:00 UTC#268071newconfirmedpress release

Tyra Biosciences to host conference call on Sept 9 for initial Phase 2 SURF302 study results of dabogratinib

pr newswireimportance 0.30trust 1.00Tyra Biosciences, Inc. +0.20Dabogratinib +0.20SURF302 +0.20

2026-08-04 21:25:38 UTC#125944newconfirmednews

Tyra Biosciences Q2 GAAP EPS of -$0.69 misses consensus estimates by $0.04

seeking alphaimportance 0.40trust 0.80Tyra Biosciences, Inc. -0.30

2026-08-04 20:05:00 UTC#125275newconfirmedpress release

Tyra Biosciences Reports Q2 2026 Results, $353.9M Cash Runway, and Pipeline Updates for SURF302 and BEACH301

pr_newswireimportance 0.40trust 1.00Tyra Biosciences, Inc. +0.10Jonathan Day +0.20SURF302 +0.20+1 entities